Journal article

Capecitabine/irinotecan in coloreetal cancer: European early-phase data and planned trials

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Kerr, D. (2002). Capecitabine/irinotecan in coloreetal cancer: European early-phase data and planned trials. ONCOLOGY-NEW YORK, 16(12), 12–15.

MLA Style

Kerr, D. “Capecitabine/Irinotecan in Coloreetal Cancer: European Early-Phase Data and Planned Trials.” ONCOLOGY-NEW YORK, vol. 16, no. 12, 2002, pp. 12–15.

Chicago Style

Kerr, D. 2002. “Capecitabine/Irinotecan in Coloreetal Cancer: European Early-Phase Data and Planned Trials.” ONCOLOGY-NEW YORK 16 (12): 12–15.
Print

Authors

+ Kerr, D More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Sub department:: Lab Sciences
Role:: Author

Journal:: ONCOLOGY-NEW YORK More from this journal
Volume:: 16
Issue:: 12
Pages:: 12-15
Publication date:: 2002-12-01
ISSN:: 0890-9091

Pubs id:: pubs:346471
UUID:: uuid:f3dc61bf-bc53-4faf-b197-89d0307b3fd7
Local pid:: pubs:346471
Source identifiers:: 346471
Deposit date:: 2013-11-16
ARK identifier:: ark:/29072/ora_f3dc61bfbc534fafb19789d0307b3fd7

Terms of use

Copyright date:: 2002

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP